PAIRS: Friend-Based AISA Intervention
State University of New York at Buffalo · NCT07433270
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18–24 · Women only
- Healthy volunteers
- Accepted
- Study type
- Interventional · Not applicable
- Target enrollment
- 560
- US sites recruiting
- 1
- Study start
- May 6, 2026
- Record last updated
- July 13, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
This Phase 2 trial will to examine the efficacy of a brief dyad-based motivational interview (PAIRS MI) delivered to friend dyads with an active treatment-as-usual condition, and a 1-year follow-up.
Being studied: Friend-Based Motivational Interview; Treatment as usual (TAU)
Conditions: Sexual Violence; College Drinking; Behavioral Changes
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Women
- 4 or more drinks in a single sitting 2 or more times monthly in the past 3 months
- does not live at home with parents
- reports going out (not necessarily drinking) with the other member of their dyad > 1/week
Exclusion Criteria
- Can not speak and understand English sufficiently
Recruiting US locations
University at Buffalo Department of Psychology
Buffalo, NY 14260
Site contact: Jennifer Read · 7168832574 · jpread@buffalo.edu
Study contacts (from the official record)
- Jennifer P Read, Ph.D. · 7166450193 · jpread@buffalo.edu
- Dylan Vlaovich · 716-310-3965 · dylanvla@buffalo.edu
Similar studies in New York
All healthy volunteers studies in New York →- RecruitingHealthy volunteers
Using Middle School Science Teachers to Address Cancer Health Disparities
Weill Medical College of Cornell University
- Location
- New York, NY + 1 other US site
- Eligibility basics
- Ages 10+
- RecruitingHealthy volunteersPhase 1/Phase 2
A Phase I/II Study of ITU512 in Healthy Participants and Patients With Sickle Cell Disease
Novartis Pharmaceuticals
- Location
- New York, NY + 7 other US sites
- Eligibility basics
- Ages 12–55
- RecruitingHealthy volunteersPhase 1/Phase 2
Phase 1/2 Study of Respiratory Syncytial Virus and Human Metapneumovirus (RSV+HMPV) Vaccine Candidate in Adults 60 Years of Age and Older
Sanofi
- Location
- Staten Island, NY + 49 other US sites
- Eligibility basics
- Ages 60+
- RecruitingHealthy volunteersPhase 1
A Clinical Study of Novel Pneumococcal Vaccine V118C in Children (V118C-002)
Merck Sharp & Dohme LLC
- Location
- East Syracuse, NY + 14 other US sites
- Eligibility basics
- Ages 2 mo–1